Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hailing Liu

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
Cell Death and Differentiation|June 25, 2024
Disrupting CCDC137-mediated LZTS2 and β-TrCP interaction in the nucleus inhibits hepatocellular carcinoma development via β-catenin and AKTLei Xu, Qiumeng Liu, Hailing Liu, et al.
Hepatology (Baltimore, Md.)|November 10, 2021
IL-6-induced cGGNBP2 encodes a protein to promote cell growth and metastasis in intrahepatic cholangiocarcinomaHui Li, Tian Lan, Hailing Liu, et al.
Scientific Reports|June 26, 2020
Temporal radiographic changes in COVID-19 patients: relationship to disease severity and viral clearanceXiaofan Liu, Hong Zhou, Yilu Zhou, et al.
The Lancet. Respiratory Medicine|May 8, 2021
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective studyXiaojun Wu, Xiaofan Liu, Yilu Zhou, et al.
Iscience|June 19, 2026
Deep-learning-based artificial intelligence approaches for grading and progression prediction of clear cell renal cell carcinomaJing Zhou, BoJin Su, Chang Zhao, et al.
Genomics, Proteomics & Bioinformatics|May 16, 2020
CRISPR Screens Identify Essential Cell Growth Mediators in BRAF Inhibitor-resistant MelanomaZiyi Li, Binbin Wang, Shengqing Gu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 4, 2026
CD96 as a Therapeutic Target for CAR T-Cell Therapy in Acute Myeloid LeukemiaXiaotong Gao, Hailing Liu, Guokun Li, et al.
American Journal of Hematology|April 26, 2026
Outcomes With First-Line PD1 Inhibitors in Extranodal NK/T-Cell Lymphoma: A Comparative Analysis From a 755-Patient Multicenter CohortHailing Liu, Mei Sun, Chunling Wang, et al.
Haematologica|July 9, 2026
Dual resistance to asparaginase and PD-1 blockade in extranodal natural killer/T-cell lymphoma: dismal outcomes from a multicenter cohortRan Li, Lixia Sheng, Jie Ma, et al.
Pharmacological Research|October 28, 2023
Characterization of the tumor microenvironment and identification of spatially predictive biomarkers associated with beneficial neoadjuvant chemoradiotherapy in locally advanced rectal cancerShifen Zhang, Na Li, Feifei Wang, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Cell Death and Differentiation|June 25, 2024
Disrupting CCDC137-mediated LZTS2 and β-TrCP interaction in the nucleus inhibits hepatocellular carcinoma development via β-catenin and AKTLei Xu, Qiumeng Liu, Hailing Liu, et al.
Hepatology (Baltimore, Md.)|November 10, 2021
IL-6-induced cGGNBP2 encodes a protein to promote cell growth and metastasis in intrahepatic cholangiocarcinomaHui Li, Tian Lan, Hailing Liu, et al.
Scientific Reports|June 26, 2020
Temporal radiographic changes in COVID-19 patients: relationship to disease severity and viral clearanceXiaofan Liu, Hong Zhou, Yilu Zhou, et al.
The Lancet. Respiratory Medicine|May 8, 2021
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective studyXiaojun Wu, Xiaofan Liu, Yilu Zhou, et al.
Iscience|June 19, 2026
Deep-learning-based artificial intelligence approaches for grading and progression prediction of clear cell renal cell carcinomaJing Zhou, BoJin Su, Chang Zhao, et al.
Genomics, Proteomics & Bioinformatics|May 16, 2020
CRISPR Screens Identify Essential Cell Growth Mediators in BRAF Inhibitor-resistant MelanomaZiyi Li, Binbin Wang, Shengqing Gu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 4, 2026
CD96 as a Therapeutic Target for CAR T-Cell Therapy in Acute Myeloid LeukemiaXiaotong Gao, Hailing Liu, Guokun Li, et al.
American Journal of Hematology|April 26, 2026
Outcomes With First-Line PD1 Inhibitors in Extranodal NK/T-Cell Lymphoma: A Comparative Analysis From a 755-Patient Multicenter CohortHailing Liu, Mei Sun, Chunling Wang, et al.
Haematologica|July 9, 2026
Dual resistance to asparaginase and PD-1 blockade in extranodal natural killer/T-cell lymphoma: dismal outcomes from a multicenter cohortRan Li, Lixia Sheng, Jie Ma, et al.
Pharmacological Research|October 28, 2023
Characterization of the tumor microenvironment and identification of spatially predictive biomarkers associated with beneficial neoadjuvant chemoradiotherapy in locally advanced rectal cancerShifen Zhang, Na Li, Feifei Wang, et al.
Pageof 18